Governor Kathy Hochul has announced the appointment of new members to New York’s Emerging Technology Advisory Board, which will focus on biotechnology. The board is an independent group composed of industry leaders who will advise on strategies to expand the state’s biotechnology sector.
The advisory board will be co-chaired by Andrew Baum, Chief Strategy and Innovation Officer at Pfizer, and Debi Brooks, CEO and Co-Founder of The Michael J. Fox Foundation. Its membership includes representatives from business, philanthropy, and research institutions across New York State.
“New York State is a national leader in biotechnology with innovative research being conducted from Long Island to Buffalo,” Governor Hochul said. “Bringing together these industry leaders from all corners of the state will help expand our biotechnology ecosystem, ensuring New York is at the forefront of life sciences and medical innovation.”
Andrew Baum commented on New York’s position in the biotech industry: “New York is uniquely positioned to lead the next wave of biotech innovation. With world-class institutions, entrepreneurial energy, and a commitment to catalytic investment, we’re building a world-class ecosystem where breakthrough therapies are developed right here in the Empire State. Through strategic partnerships, we are confident New York can thrive and expand upon the strong foundation that exists today as the nation’s emerging global leader in life sciences innovation.”
Debi Brooks added: “I’m honored to be appointed to co-chair New York’s Emerging Technology Advisory Board. Together, this Board has the chance to advance public–private partnerships across New York’s biotech sector and deliver breakthroughs that patients and families urgently deserve. At The Michael J. Fox Foundation, we’ve witnessed how strategic collaboration, emerging science and cutting-edge tools can help speed progress. I thank Governor Hochul for convening this group and prioritizing investment in life sciences. I look forward to joining my fellow members of the Board in shaping the future of biotechnology in New York State.”
Hope Knight, President, CEO and Commissioner of Empire State Development, stated: “New York State has become a powerhouse for innovation by bringing together world-class researchers, industry leaders, and forward-looking institutions. The creation of this Emerging Technology Advisory Board will further strengthen our life sciences ecosystem by ensuring that breakthrough ideas in biotechnology can be nurtured, commercialized, and scaled right here in New York. Under Governor Hochul’s leadership, we are not only accelerating scientific discovery but also creating the jobs and opportunities that will define the future of our economy.”
The initiative supports ongoing efforts by state leadership to establish New York as a prominent center for life sciences research and advanced manufacturing.
